Gilissen; Ronaldus Arnodus Hendrika Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gilissen; Ronaldus Arnodus Hendrika Joseph.The latest application filed is for "pyrazolyl quinoxaline kinase inhibitors".

Company Profile

6.11.13

Gilissen; Ronaldus Arnodus Hendrika Joseph - Kasterlee BE
Gilissen; Ronaldus Arnodus Hendrika Joseph - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolyl Quinoxaline Kinase Inhibitors App 20220135544 - SAXTY; Gordon ; et al.	2022-05-05
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 11,318,157 - Wu , et al. May 3, 2	2022-05-03
Substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,898,504 - Berthelot , et al. January 26, 2	2021-01-26
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200360416 - Wu; Tongfei ; et al.	2020-11-19
Novel Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200289539 - BERTHELOT; Didier Jean-Claude ; et al.	2020-09-17
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,653,711 - Wu , et al.	2020-05-19
Pyrazolyl Quinoxaline Kinase Inhibitors App 20200131153 - SAXTY; Gordon ; et al.	2020-04-30
Deuterated triazolopyridazine as a kinase modulator Grant 10,464,939 - Furer , et al. No	2019-11-05
Deuterated Triazolopyridazine As A Kinase Modulator App 20190031670 - Furer; Patrick Blasius ; et al.	2019-01-31
Deuterated triazolopyridazine as a kinase modulator Grant 10,138,246 - Furer , et al. Nov	2018-11-27
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20180243328 - Wu; Tongfei ; et al.	2018-08-30
Pyrazolyl Quinoxaline Kinase Inhibitors App 20180127397 - SAXTY; Gordon ; et al.	2018-05-10
Pyrazolyl quinoxaline kinase inhibitors Grant 9,850,228 - Saxty , et al. December 26, 2	2017-12-26
A Deuterated Triazolopyridazine As A Kinase Modulator App 20170267684 - Furer; Patrick Blasius ; et al.	2017-09-21
Pyrazolyl Quinoxaline Kinase Inhibitors App 20160311800 - SAXTY; Gordon ; et al.	2016-10-27
Pyrazolyl quinoxaline kinase inhibitors Grant 9,464,071 - Saxty , et al. October 11, 2	2016-10-11
Pyrazolyl Quinoxaline Kinase Inhibitors App 20150105368 - SAXTY; Gordon ; et al.	2015-04-16
Pyrazolyl quinoxaline kinase inhibitors Grant 8,895,601 - Saxty , et al. November 25, 2	2014-11-25
Pyrazolyl Quinazoline Kinase Inhibitors App 20130072457 - Saxty; Gordon ; et al.	2013-03-21
Adamantyl acetamides as 11-.beta. hydroxysteroid dehydrogenase inhibitors Grant 7,968,601 - Linders , et al. June 28, 2	2011-06-28
Adamantyl Acetamides As 11-beta Hydroxysteroid Dehydrogenase Inhibitors App 20080096869 - Linders; Joannes Theodorus Maria ; et al.	2008-04-24
Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors Grant 7,332,524 - Linders , et al. February 19, 2	2008-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.